Article
Phase II study of gemcitabine in children with solid tumors of mesenchymal and embryonic origin
1 Aug 2006
Abstract excerpt
Among the several different combination chemotherapy regimens for the treatment of patients with metastatic colorectal cancer, oxaliplatin plus raltitrexed has shown encouraging therapeutic results and a fairly good toxicity profile. Here, we report on two patients with metastatic colorectal cancer receiving this combination therapy, which leads to severe enterocolitis and neutropenia resulting in death in one...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
